Advertisement
UK markets close in 1 hour 46 minutes
  • FTSE 100

    8,053.10
    +12.72 (+0.16%)
     
  • FTSE 250

    19,604.98
    -114.39 (-0.58%)
     
  • AIM

    753.56
    -1.13 (-0.15%)
     
  • GBP/EUR

    1.1662
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2477
    +0.0014 (+0.11%)
     
  • Bitcoin GBP

    50,752.63
    -2,342.17 (-4.41%)
     
  • CMC Crypto 200

    1,347.14
    -35.44 (-2.56%)
     
  • S&P 500

    5,006.17
    -65.46 (-1.29%)
     
  • DOW

    37,941.01
    -519.91 (-1.35%)
     
  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     
  • GOLD FUTURES

    2,331.70
    -6.70 (-0.29%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,863.93
    -224.77 (-1.24%)
     
  • CAC 40

    7,976.05
    -115.81 (-1.43%)
     

Behind Dentsply Sirona’s Total Impairment Charges in 2017

Behind Dentsply Sirona’s Total Impairment Charges in 2017

Dentsply Sirona (XRAY) updated its estimates and assumptions during fiscal 2Q17 and underwent an annual impairment test of goodwill. According to company estimates, the goodwill charges associated with some of its technologies segment businesses, including CAD-CAM imaging and its treatment center, came from impairment. The company recorded nearly $1.1 billion in goodwill impairment charges in 2Q17 and $581 million in 4Q17, for a total of ~$1.67 billion in fiscal 2017. Meanwhile, the company undertook an annual impairment assessment of indefinite-lived intangible assets.